, Singapore
356 views
Photo from Envato Elements

Disa unit inks licensing agreement to commercialise cataract screening device

The agreement was signed with NUH and NUS.

Digital Life Line (DLL), a DiSa Digital Safety unit, signed a tri-party licensing agreement with the National University Hospital (NUH) and the National University of Singapore (NUS) to commercialise a portable cataract screening device.

The Mobile Imaging Device for Anterior Segment (MIDAS) is used with smartphones to image the lens of the eye to ascertain the level of cloudiness that correlates with the severity of cataracts.

It provides information to identify individuals who need referral to cataract specialists for follow-up.

Developed by the Department of Ophthalmology at NUH and NUS' Centre for Innovation, Precision Eye Health, MIDAS is registered with the Health Sciences Authority of Singapore. It is designed for use by patients, nurses, and primary care physicians.

“Our in-house developed AI algorithms can eliminate the need for trained staff to identify the best image and process the cataract grading parameters within 10 seconds. By harnessing intelligent triaging based on an established cataract grading system, we aim to ensure that each referral is both timely and accurate,” Eddie Chng, managing director and CEO of DLL said.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.